000 01156 a2200325 4500
005 20250514235303.0
264 0 _c20060131
008 200601s 0 0 eng d
022 _a0342-4642
024 7 _a10.1007/s00134-005-2740-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMatejovic, Martin
245 0 0 _aNoradrenaline and the kidney: foe, friend, or both?
_h[electronic resource]
260 _bIntensive care medicine
_cNov 2005
300 _a1476-8 p.
_bdigital
500 _aPublication Type: Comment; Editorial; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDogs
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aInfusions, Intravenous
650 0 4 _aKidney
_xdrug effects
650 0 4 _aNorepinephrine
_xadministration & dosage
650 0 4 _aRenal Circulation
_xdrug effects
650 0 4 _aShock, Septic
_xdrug therapy
650 0 4 _aSympathomimetics
_xadverse effects
700 1 _aTräger, Karl
700 1 _aDe Backer, Daniel
773 0 _tIntensive care medicine
_gvol. 31
_gno. 11
_gp. 1476-8
856 4 0 _uhttps://doi.org/10.1007/s00134-005-2740-z
_zAvailable from publisher's website
999 _c15726624
_d15726624